首页> 外文期刊>Critical care : >A randomized controlled trial on the effects of goal-directed therapy on the inflammatory response open abdominal aortic aneurysm repair
【24h】

A randomized controlled trial on the effects of goal-directed therapy on the inflammatory response open abdominal aortic aneurysm repair

机译:目标导向疗法对开腹腹主动脉瘤炎性反应的影响的随机对照试验

获取原文
获取外文期刊封面目录资料

摘要

IntroductionGoal-directed therapy (GDT) has been shown in numerous studies to decrease perioperative morbidity and mortality. The mechanism of benefit of GDT, however, has not been clearly elucidated. Targeted resuscitation of the vascular endothelium with GDT might alter the postoperative inflammatory response and be responsible for the decreased complications with this therapy.MethodsThis trial was registered at ClinicalTrials.gov as NCT01681251. Forty patients undergoing elective open repair of their abdominal aortic aneurysm, 18?years of age and older, were randomized to an interventional arm with GDT targeting stroke volume variation with an arterial pulse contour cardiac output monitor, or control, where fluid therapy was administered at the discretion of the attending anesthesiologist. We measured levels of several inflammatory cytokines (C-reactive protein, Pentraxin 3, suppressor of tumorgenicity--2, interleukin-1 receptor antagonist, and tumor necrosis factor receptor-III) preoperatively and at several postoperative time points to determine if there was a difference in inflammatory response. We also assessed each group for a composite of postoperative complications.ResultsTwenty patients were randomized to GDT and twenty were randomized to control. Length of stay was not different between groups. Intervention patients received less crystalloid and more colloid. At the end of the study, intervention patients had a higher cardiac index (3.4?±?0.5 vs. 2.5?±?0.7?l/minute per m2, p?
机译:引言在许多研究中已表明目标导向疗法(GDT)可降低围手术期的发病率和死亡率。但是,尚未明确阐明GDT的利益机制。使用GDT进行血管内皮靶向复苏可能会改变术后炎症反应,并导致这种疗法的并发症减少。方法该试验已在ClinicalTrials.gov上注册为NCT01681251。 40名年龄在18岁及以上的接受腹主动脉瘤选择性开放修补的患者被随机分配到GDT干预组,该组以卒中量变化为目标,并通过动脉搏动轮廓心输出量监测器或对照进行输液治疗。主治麻醉师的酌处权。我们在术前和术后几个时间点测量了几种炎性细胞因子(C反应蛋白,Pentraxin 3,抑癌性-2,白介素-1受体拮抗剂和肿瘤坏死因子受体-III)的水平,以确定是否存在炎症反应的差异。结果还对每组患者的术后并发症进行了评估。结果20例患者被随机分为GDT,20例被随机分为对照组。两组之间的住院时间没有差异。干预患者接受的晶体较少,而胶体较多。在研究结束时,干预患者的心脏指数更高(3.4 /±0.5 0.5 vs. 2.5 /±0.7μl/ min / m2,p <0.01)和中风量指数(50.1±7.4)与对照组相比为38.1±±9.8ml / m2,p << 0.01。干预组的并发症明显少于对照组(28比12,p = 0.02)。两组患者的住院时间和ICU住院时间无差异。两组之间的炎症细胞因子水平没有差异。结论尽管并发症少,血液动力学改善,但GDT治疗的炎症反应没有差异。这表明尽管有相似的炎症负担,GDT仍具有临床益处。尚需进行进一步的工作来描述GDT的利益机制。试用注册ClinicalTrials.gov标识符:NCT01681251。 2011年5月18日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号